Molecular farming can be defined as the use of plants to produce recombinant protein
products. The technology is now> 30 years old. The early promise of molecular farming was …

Plants can be engineered to recombinantly produce high-quality proteins such as
therapeutic proteins and vaccines, also known as molecular farming. Molecular farming can …

Herbal remedies were the first medicines used by humans due to the many
pharmacologically active secondary metabolites produced by plants. Some of these …

Plants offer fast, flexible and easily scalable alternative platforms for the production of
pharmaceutical proteins, but differences between plant and mammalian N‐linked glycans …

The ability to express heterologous proteins in plants has led to the concept of using plants
as “bioreactors” or “biofactories” for the production of pharmaceutical proteins. Although …

Gene technology has facilitated the biologization of manufacturing, ie the use and
production of complex biological molecules and systems at an industrial scale. Monoclonal …

Plants have unique advantages over other systems such as mammalian cells for the
production of valuable small molecules and proteins. The benefits cited most often include …

Biopharmaceuticals are a large and fast-growing sector of the total pharmaceutical market
with antibody-based therapeutics accounting for over 100 billion USD in sales yearly …

Infectious diseases, also known as transmissible or communicable diseases, are caused by
pathogens or parasites that spread in communities by direct contact with infected individuals …

Immune checkpoint inhibitors (ICIs) have achieved huge clinical success. However, many
still have limited response rates, and are prohibitively costly. There is a need for effective …